Cadila Pharma and the Russian Direct Investment Fund will jointly provide over $100 million for a new plant Indian company Cadila Pharmaceuticals and the Russian Direct Investment Fund (RDIF) have agreed to jointly finance the first stage of a new manufacturing facility in Russia, according to a statement on Thursday. The agreement comes after numerous Western competitors withdrew from Russia due to Ukraine-related sanctions, boosting India’s role in supplying medicines to the country. According to the agreement signed on the sidelines of the St. Petersburg International Economic Forum (SPIEF), the parties will pr
Hence then, the article about spief 2024 indian pharma giant to expand presence in russia was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( SPIEF 2024: Indian pharma giant to expand presence in Russia )